Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) EBT Margin (2016 - 2025)

STRATA Skin Sciences' EBT Margin history spans 14 years, with the latest figure at 37.21% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 8656.0% to 37.21% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.32%, a 2381.0% increase, with the full-year FY2025 number at 20.2%, up 1036.0% from a year prior.
  • EBT Margin hit 37.21% in Q4 2025 for STRATA Skin Sciences, up from 23.41% in the prior quarter.
  • Over the last five years, EBT Margin for SSKN hit a ceiling of 37.21% in Q4 2025 and a floor of 49.84% in Q1 2024.
  • Historically, EBT Margin has averaged 20.83% across 5 years, with a median of 23.49% in 2025.
  • Biggest five-year swings in EBT Margin: crashed -4381bps in 2023 and later surged 8656bps in 2025.
  • Tracing SSKN's EBT Margin over 5 years: stood at 9.13% in 2021, then surged by 90bps to 0.91% in 2022, then crashed by -4788bps to 44.72% in 2023, then fell by -10bps to 49.34% in 2024, then soared by 175bps to 37.21% in 2025.
  • Business Quant data shows EBT Margin for SSKN at 37.21% in Q4 2025, 23.41% in Q3 2025, and 33.6% in Q2 2025.